Healthpeak Properties (NYSE:DOC – Get Free Report) had its target price raised by stock analysts at UBS Group from $20.00 to $22.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage currently has a “neutral” rating on the real estate investment trust’s stock. UBS Group‘s price objective would indicate a potential upside of 7.87% from the company’s previous close.
A number of other brokerages have also recently issued reports on DOC. Jefferies Financial Group initiated coverage on Healthpeak Properties in a report on Tuesday, September 15th. They set a “hold” rating and a $21.00 target price on the stock. Robert W. Baird upped their price target on Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a research note on Thursday, August 13th. Weiss Ratings upgraded shares of Healthpeak Properties from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday. Wall Street Zen lowered shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Saturday. Finally, Cantor Fitzgerald decreased their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set a “neutral” rating for the company in a report on Wednesday, November 4th. Four analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $21.60.
Read Our Latest Analysis on DOC
Healthpeak Properties Trading Down 0.1%
Shares of DOC stock traded down $0.02 during trading hours on Wednesday, reaching $20.39. The company had a trading volume of 3,506,235 shares, compared to its average volume of 7,634,237. Healthpeak Properties has a 1-year low of $15.70 and a 1-year high of $22.95. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.29 and a quick ratio of 1.29. The firm has a market cap of $14.06 billion, a price-to-earnings ratio of 37.77, a P/E/G ratio of 2.54 and a beta of 1.01. The company has a 50 day moving average of $19.73 and a 200 day moving average of $19.22.
Healthpeak Properties (NYSE:DOC – Get Free Report) last announced its quarterly earnings data on Monday, November 2nd. The real estate investment trust reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.41). The company had revenue of $820.89 million for the quarter, compared to analyst estimates of $739.18 million. Healthpeak Properties had a return on equity of 4.04% and a net margin of 12.32%. The firm’s revenue for the quarter was up 16.3% on a year-over-year basis. During the same period last year, the firm earned $0.46 earnings per share. On average, equities research analysts anticipate that Healthpeak Properties will post 1.77 EPS for the current year.
Insider Activity
In related news, EVP Ankit Patadia sold 6,115 shares of the stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $20.78, for a total transaction of $127,069.70. Following the completion of the sale, the executive vice president directly owned 2,838 shares of the company’s stock, valued at approximately $58,973.64. This represents a 68.30% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.23% of the company’s stock.
Hedge Funds Weigh In On Healthpeak Properties
Large investors have recently added to or reduced their stakes in the company. Pension & Wealth Management Advisors Inc. acquired a new position in shares of Healthpeak Properties during the third quarter worth about $27,000. Clearstead Trust LLC lifted its stake in Healthpeak Properties by 66.7% in the 2nd quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust’s stock valued at $29,000 after acquiring an additional 543 shares in the last quarter. Security National Bank of SO Dak bought a new stake in Healthpeak Properties in the 2nd quarter valued at approximately $32,000. Latitude Advisors LLC bought a new stake in Healthpeak Properties in the 3rd quarter valued at approximately $34,000. Finally, Markowski Investments acquired a new position in Healthpeak Properties during the 2nd quarter worth approximately $38,000. Institutional investors own 93.57% of the company’s stock.
About Healthpeak Properties
Healthpeak Properties, Inc. is a real estate investment trust that owns and operates properties serving the healthcare and life sciences industries. Its portfolio includes outpatient medical buildings, life science facilities and senior housing communities. The company’s properties are located across the United States, with investments in major healthcare and life science markets. In 2024, Healthpeak completed its merger with Physicians Realty Trust, expanding its portfolio of outpatient medical properties.
Read More
- Five stocks we like better than Healthpeak Properties
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
